The Fecal Immunochemical Diagnostic Test (FIT) Market Size was valued at USD 1.36 Bn in 2023 and is predicted to reach USD 2.03 Bn by 2031 at a 5.29% CAGR during the forecast period for 2024-2031.
The fecal immunochemical diagnostic test (FIT) is a non-invasive screening tool that can detect hidden blood in feces, which can be an early sign of colon cancer or other gastrointestinal disorders. There are numerous main drivers behind the market for fecal immunochemical tests (FIT). Demand for frequent screening examinations is greatly raised by the expanding elderly population, which increases colorectal cancer risk. This demographic trend emphasizes the need for early diagnosis and preventative medical actions. Furthermore, the development of diagnostic tools and healthcare infrastructure improves access to sophisticated testing techniques, therefore promoting a more general acceptance of FIT. By encouraging frequent colorectal cancer testing, raising public awareness, and funding and support for screening campaigns, government initiatives and screening programs significantly help. These elements are driving FIT’s expansion around the world.
However, market expansion is hindered by high costs, restrictive reimbursement rules, and ignorance of the need for colorectal cancer screening. The fecal immunochemical diagnostic test (FIT) industry suffered a hit during the COVID-19 pandemic because fewer patients visited healthcare institutions, and regular examinations were postponed. However, the pandemic brought attention to the significance of non-invasive home testing kits, which sparked a new wave of interest and drove expansion in the FIT market. Additionally, fecal immunochemical diagnostic test (FIT) further propelled market expansion and are in great demand because developments in testing technology, rising research funding, and technological improvements are boosting the fecal immunochemical diagnostic test (FIT) market by improving detection accuracy and efficiency, which in turn ensures compliance with security criteria and safeguarding public health.
The global fecal immunochemical diagnostic test (FIT) market is segmented based on product and end-user. By product, the market is divided into kits and reagents, analyzers, and others. By end-user, it is divided into hospitals and diagnostics laboratories, specialty clinics, home care settings, and research institutes.
The kits & reagents in the fecal immunochemical diagnostic test (FIT) market are expected to hold a major global market share in 2023 because of their vital part in test dependability and correctness. Their appeal stems from the growing need for early colorectal cancer screening as well as from home testing kit ease. Furthermore, supporting their market growth are continuous developments in reagent technology, which improve test sensitivity and specificity.
The hospitals and diagnostic laboratories segment in the fecal immunochemical diagnostic test (FIT) market is growing due to the growing focus on early identification and consistent colorectal cancer screening. These facilities provide accurate and dependable test findings by means of access to sophisticated diagnostic tools and qualified personnel. Furthermore, aiding their development in the market are the increasing frequency of gastrointestinal diseases and the growing healthcare infrastructure in many areas, which stimulate demand for FIT testing in hospitals and diagnostic laboratories.
The North American global fecal immunochemical diagnostic test (FIT) market is expected to register the highest market share in revenue in the near future. This is because friendly government policies endorsing consistent screening, leading diagnostic corporations, and the acceptance of cutting-edge technologies help to strengthen the market even more. Furthermore, driving the rising demand for fecal immunochemical diagnostic tests in America are aging populations and the rising frequency of gastrointestinal problems. In addition, the Asia Pacific is anticipated to grow rapidly in the global fecal immunochemical diagnostic test (FIT) market because of the presence of important participants in the industry, and continuous R&D initiatives support the growth of the market. Moreover, the well-developed healthcare systems, strong government programs encouraging early diagnosis, and heightened public awareness of the need for colorectal cancer screening are helping to propel the market forward.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.36 Bn |
|
Revenue Forecast In 2031 |
USD 2.03 Bn |
|
Growth Rate CAGR |
CAGR of 5.29% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Quest Diagnostics Incorporated and Sentinel CH. SpA, FUJIFILM Corporation, Quidel Corporation, Danaher (Beckman Coulter, Inc.), Eiken Chemical Co., Ltd., Freenome Holdings, Inc., Immunostics, Inc., BTNX, Inc., and Biohit Oyj. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fecal Immunochemical Diagnostic Test (FIT) Market Snapshot
Chapter 4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Kits & Reagents
5.2.2. Analyzers
5.2.3. Others
Chapter 6. Market Segmentation 2: By End-user Estimates & Trend Analysis
6.1. By End-user & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-user:
6.2.1. Hospitals & Diagnostics Laboratories
6.2.2. Specialty Clinics
6.2.3. Home Care Settings
6.2.4. Research Institutes
Chapter 7. Fecal Immunochemical Diagnostic Test (FIT) Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.1.2. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.1.3. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.2.2. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.2.3. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.3.2. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.3.3. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.4.2. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.4.3. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.5.2. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.5.3. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Quest Diagnostics Incorporated
8.2.2. Sentinel CH. SpA
8.2.3. FUJIFILM Corporation
8.2.4. Quidel Corporation
8.2.5. Danaher (Beckman Coulter, Inc.)
8.2.6. Eiken Chemical Co., Ltd
8.2.7. Freenome Holdings, Inc.
8.2.8. Immunostics, Inc.
8.2.9. BTNX, Inc.
8.2.10. Biohit Oyj.
8.2.11. Other Prominent Players
Fecal Immunochemical Diagnostic Test (FIT) Market- By Product
Fecal Immunochemical Diagnostic Test (FIT) Market- By End-User
Fecal Immunochemical Diagnostic Test (FIT) Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
